Grants, Research, and Publications
Grants
Through grants, Ideal Option offers supplemental programs and support across the country to provide low barrier access to medication-assisted treatment for individuals with substance use disorder.
New Mexico
Statewide MAT Provider Workgroup
Ideal Option received funding from the New Mexico Department of Health to build overdose prevention capacity as a part of health promotion efforts to enhance local knowledge of problematic substance use, harm reduction, and access to medication-based treatment (MAT) as well as contribute to evaluation of local, regional, and statewide community efforts to help prevent fatal and nonfatal drug overdoses in New Mexico.
New Mexico
Doña Ana County Intensive Case Management
Ideal Option provides Intensive Case Management for adults involved or at risk of involvement in the criminal justice system. According to the National Association of Social Workers the goal of case management is to “enhance a client’s purpose and well-being by providing and coordinating high-quality, services, in the most effective and efficient manner possible, for individuals with multiple complex needs”. Intensive Case Management covers all essential supports of conventional case management, such as housing, benefits, legal, and medical referrals, and advocacy.
New Mexico
Doña Ana County Uninsured
Doña Ana County’s program aims to fund and support initiatives that improve the health and wellness of the Doña Ana County community. Ideal Option has been awarded funding and is using these funds to provide substance use disorder treatment to uninsured patients at our clinic in Las Cruces, NM.
Oregon
Drug Addiction Treatment and Recovery Act (M110)
In November of 2020 Oregon passed measure 110 or the Drug Addiction Treatment and Recovery Act. This led to grant funds being available for Behavioral Health Resource Networks (BHRNs) to provide communities with prevention, treatment, and recovery services to individuals with and at risk for substance use disorder. Ideal Option is using these funds for the following projects:
- Provide substance use disorder treatment to uninsured Oregonians in Deschutes, Marion, and Washington Counties.
- Support peer outreach services across Oregon.
- Open a second clinic location in Lane County: The Springfield Oregon clinic opened on February 20th , 2023.
- Open a second clinic in Deschutes County: The Redmond Oregon clinic opened on January 23rd, 2023.
- Provide Medication Assisted Treatment within the Deschutes County Jail: The program launched in July 2023.
- Provide Medication Assisted Treatment within the Marion County Jail: The program launched in January 2023.
Washington
Hub & Spoke
Ideal Option received Washington Health Care Authority (HCA) funding for the Hub & Spoke (H&S) project. Since then, Ideal Option has successfully inducted individuals and coordinated recovery support services for those seeking access to medications for opioid use disorder (MOUD) in Snohomish and Skagit counties. Ideal Option’s network includes partners providing detox, primary care, SUD counseling, mental health counseling and transportation services.
Washington
Seattle LEAD
The LEAD program diverts individuals who are engaged in low-level drug crime and crimes of poverty away from the criminal legal system and connects them with intensive case managers who can provide crisis response, immediate psychosocial assessment, and access to long-term wrap-around services including substance use disorder treatment and housing. The City of Seattle contracts with PDA (Purpose. Dignity. Action.) to administer the LEAD program and Ideal Option is one of the organizations who provides case management services.
Washington
Snohomish County Peer – Peer Navigation Services
Peer navigation services are completed by a person who has lived experience, helping people who are currently experiencing substance use, mental health challenges, and/or houselessness find and access the services they are ready to receive. Peer navigators liase between individuals, healthcare providers, and service providers, facilitating communications and ensuring all parties are in agreement and clear on all important decisions. Through shared understanding, respect, and mutual empowerment, peer navigators help people become and stay engaged in the recovery process and reduce the likelihood of relapse. This project places a peer navigator within the Emergency Room at Providence in Everett and another in the Snohomish County Jail.
Washington
MAT Expansion – Maple Falls, WA
The outpatient clinic in Maple Falls is open for new and returning patients on Wednesdays, 9:00 a.m. – 4 p.m. at 8251 Kendall Rd, inside the East Whatcom Regional Resource Center. The purpose of the project, funded by the North Sound Accountable Community of Health (ACH), is to expand access to office-based opioid treatment to the HRSA and USDA designated rural community of Maple Falls.
Washington
North Sound ACH Community Hub
North Sound ACH supports a regional care coordination hub, which takes referrals from across the region about individuals and families struggling due to physical, behavioral, and social needs. The Community Hub serves as a central registry for a network of care coordination agencies (CCAs), helping to eliminate structural barriers while reducing the duplication of services. The Hub also serves as the central infrastructure for tracking and measuring specific health outcomes, agency outcomes, staff outcomes, and opportunities for coordinated quality improvement efforts. Ideal Option is funded through the North Sound ACH to be one of the CCA organizations providing case management and accepting referrals for substance use disorder treatment. The program provides the community with two dedicated peer navigators withing Ideal Option clinics in Bellingham and Mount Vernon Washington to help clients navigate complicated systems and identify needed resources. The case management services provided through the Community Hub are free of charge.
Washington
Snohomish County TOF
Novel Substances are increasingly affecting communities and individuals in substance use disorder (SUD) treatment programs. Identifying the specific substances present in the local drug supply is critical for shaping effective public health initiatives and tailoring patient treatment plans. In the summer of 2024, Snohomish County Public Health, in collaboration with Ideal Option, launched a project using a Time-of-Flight (TOF) mass spectrometer to analyze samples from patients seeking treatment in Snohomish County, Washington. This initiative aims to identify emerging drug trends and provide real-time data on NPS prevalence. Approximately 150 new patients are assessed monthly across five clinics, following the clinic’s standard care practices. Although patient samples are de-identified, aggregate data analysis enables the evaluation of trends related to characteristics such as zip code, age, demographics, and substance use history. The project hopes to explore the potential of real-time novel substance surveillance and detection to enhance clinical and public health responses, particularly in preventing overdoses and improving patient outcomes.
Research
Little Rock, Arkansas
OptiMAT Study – University of Arkansas for Medical Sciences
OptiMAT (or “Optimizing Medication-Assisted Treatment”) is a health and wellness app under evaluation at the University of Arkansas for Medical Sciences. Medication-assisted treatment, or MAT, is the use of medications combined with therapy to treat substance use disorders, including misuse of nicotine, alcohol, or opioids. UAMS is evaluating if OptiMAT can improve treatment outcomes through the following:
- daily monitoring of participant craving, mood, and withdrawal symptoms
- personalized feedback
- alerting participants when they enter areas of high risk for relapse
Albuquerque, New Mexico
Data Collection for the VOICES Study – A Project of the Bloomberg Overdose Prevention Initiative of Opioid Use Disorder
The purpose of this randomized, controlled trial in Phase I is to determine whether the Pillsy intervention can improve adherence to buprenorphine-naloxone compared to Service As Usual.
PIRE staff conduct data collection to inform policy and funding decisions and support the work of the Bloomberg Overdose Prevention Initiative in four states (Wisconsin, New Jersey, Michigan, and New Mexico) with partners from Johns Hopkins Bloomberg School of Public Health and Vital Strategies. Both quantitative and qualitative data collection are conducted with people who currently or have recently been at risk of overdose through anonymous telephone surveys and in-depth interviews. Areas of focus include drug use experience, access to harm reduction and treatment services, perceptions of risk, and overdose experience.
Publications and Presentations
Medication Adherence Platform for Buprenorphine (MAP4BUP): A Phase I Feasibility, Usability and Efficacy Pilot Randomized Clinical Trial
McPherson, S. M., Smith, C. L., Hall, L., Miguel, A., Bowden, T., Keever, A., ... & LeBrun, J. (2024). Mobile Medication Adherence Platform for Buprenorphine (MAP4BUP): A Phase I Feasibility, Usability and Efficacy Pilot Randomized Clinical Trial. Drug and Alcohol Dependence, 111099.
McPherson, S.M., Smith, C.L., Hall, L., Miguel, A., Bowden, T., Keever, A., Schmidt, A., Olson, K., Rodin, N., McDonell, M.G., Roll, J.M., LeBrun J. (2023). Mobile Medication Adherence Platform for Buprenorphine (MAP4BUP): A Phase I Feasibility, Usability and Efficacy Randomized Clinical Trial. Poster presented at the annual meeting of the College on Problems of Drug Dependence (CPDD) Denver, CO. June, 2023.
What are We Missing? Detecting Novel Substances in Patients Receiving Treatment for Substance Use Disorder.
Figueroa, D. He, K. Gaulke, M. Newcombe, D. Olson, K. Dawson, B. (April 2023). Poster Presentation at RxSummit, Atlanta
Partnerships for Integrating Outpatient Medication Assisted Treatment Into Local Public Health: Increasing Access to Treatment in Rural Idaho
Dawson, B. Olson, K. Orlando, K. (April 12, 2023). Oral presentation at RxSummit, Atlanta
Long-term buprenorphine treatment for kratom use disorder: A case series
Viktoriya R. Broyan, Jessica K. Brar, Tristen Allgaier, Student & Jeffrey T. Allgaier (2022) Long-term buprenorphine treatment for kratom use disorder: A case series, Substance Abuse, 43:1, 763-766. Read the Study
Provider Reactions to Opioid-Prescribing Report Cards
Alishahi, Musheng L. MS; Olson, Katie MPH; Brooks-Russell, Ashley PhD, MPH; Hoppe, Jason DO; Runyan, Carol PhD, MPH Provider Reactions to Opioid-Prescribing Report Cards, Journal of Public Health Management and Practice: May 13, 2021 - Volume Publish Ahead of Print - Issue - DOI: Read the Study
The Impact of a PDMP-EHR Data Integration Combined With Clinical Decision Support on Opioid and Benzodiazepine Prescribing Across Clinicians in a Metropolitan Area
Calcaterra, S. L., Butler, M., Olson, K., & Blum, J. (2021). The Impact of a PDMP-EHR Data Integration Combined With Clinical Decision Support on Opioid and Benzodiazepine Prescribing Across Clinicians in a Metropolitan Area. Journal of addiction medicine, Advance online publication. Read the Study
Long-term Buprenorphine Treatment for Loperamide Use Disorder: A Case Series
Brar, Jessica K. BS; Broyan, Viktoriya R. MS; Allgaier, Jeffrey T. MD, FACEP, FASAM; Nye, Larry PA-C; Saxon, Andrew J. MD Long-term Buprenorphine Treatment for Loperamide Use Disorder: A Case Series, Journal of Addiction Medicine: November/December 2020 - Volume 14 - Issue 6 - p e378-e381 Read the Study
Definitive urine drug testing in office-based opioid treatment: a literature review
Andrea G. Barthwell, Jeffrey Allgaier & Kenneth Egli (2018) Definitive urine drug testing in office-based opioid treatment: a literature review, Critical Reviews in Toxicology, 48:10, 815-838, DOI: Read the Study
Patient Feedback on a Mobile Medication Adherence Platform for Opioid Relapse Prevention
Smith, C.L., Keever, A., Bowden, T., Smoody, G., Olson, K., McDonell, M.G., Roll, J., McPherson, S. (May 2022) Patient Feedback on a Mobile Medication Adherence Platform for Opioid Relapse Prevention. Poster to be presented at the Society for Prevention Research 30th Annual Meeting, Seattle, WA.
Bringing Transparency to Treatment: Evaluation of Patient Outcomes
Dawson, B., Olson, K. (April 2022). Bringing Transparency to Treatment: Evaluation of Patient Outcomes. Poster presented at the RxSummit conference, Atlanta, GA.
Bridging the Gap between Incarceration and Treatment for Individuals with Opioid Use Disorder in Benton County, Washington
Combs, J., Dawson, B., Roberts, A. (November 2020). Bridging the Gap between Incarceration and Treatment for Individuals with Opioid Use Disorder in Benton County, Washington. Virtual presentation at National Commission on Correctional Health Care Conference.
Use of QTOF to Detect Novel Psychoactive Substances in Patients Receiving Treatment for Substance Use Disorder
Figueroa, D, He, K and Newcombe, DA. (May 2022). Use of QTOF to Detect Novel Psychoactive Substances in Patients Receiving Treatment for Substance Use Disorder. Poster presentation given by D. Newcombe at the 2022 Mass Spectrometry in the Clinical Laboratory Conference, Monterey, CA.
Integrating Hepatitis C treatment in Substance Use Disorder Treatment through Coordinated Nurse Care Managers
Morris, S., Dawson, B., & Olson, K. (2024, April 4). Integrating Hepatitis C treatment in Substance Use Disorder Treatment through Coordinated Nurse Care Managers. Oral Presentation at RxSummit 2024, Atlanta, GA, United States.
Oregon's M110 Implementation in Central Oregon: Deschutes County
Cartwright, B., Olson, K., & Corless, L. (2024, April 2). Oregon's M110 Implementation in Central Oregon: Deschutes County. Poster Presentation at RxSummit 2024, Atlanta, GA, United States.
Identification and Characterization of Unrecognized Compounds including Novel Psychoactive Substances and Fentanyl Analogs in Individuals Undergoing Substance Use Disorder Treatment: A Comprehensive Analysis
Dawson, B., Olson, K., Newcombe, D., & Gaulke, M. (2024, June 18). Identification and Characterization of Unrecognized Compounds including Novel Psychoactive Substances and Fentanyl Analogs in Individuals Undergoing Substance Use Disorder Treatment: A Comprehensive Analysis. Poster presented at The College on Problems of Drug Dependence (CPDD) 86th Annual Scientific Meeting, Montreal, Quebec, Canada.